scAtria single-cell spatial atlas resource

NSCLC_38242124 · IMC / Imaging Mass Cytometry

NSCLC_38242124 · NSCLC_38242124__IMC

IMC / Imaging Mass Cytometry Spatial proteomics Curated Tiered

Spatial Domain

Download spatial tables

Spatial Domain (Tier 1)

2,069 ready
Sample Organ Disease state Cells Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. Domain share Purity Diversity
NSCLC_38242124__IMC__178_B6,14 Lung Primary cancer 3,953 Tumor/Malignant 39.8% 0.99 0.04
NSCLC_38242124__IMC__178_B6,15 Lung Primary cancer 2,326 Tumor/Malignant 45.4% 0.86 0.36
NSCLC_38242124__IMC__178_B6,17 Lung Primary cancer 1,683 Other 30.1% 0.82 0.42
NSCLC_38242124__IMC__178_B6,18 Lung Primary cancer 3,185 Tumor/Malignant 38.3% 1.00 0.05
NSCLC_38242124__IMC__178_B6,2 Lung Primary cancer 3,176 Other 24.3% 0.46 0.96
NSCLC_38242124__IMC__178_B6,3 Lung Primary cancer 2,771 Tumor/Malignant 37.4% 0.92 0.28
NSCLC_38242124__IMC__178_B6,4 Lung Primary cancer 2,586 Tumor/Malignant 69.8% 0.95 0.15
NSCLC_38242124__IMC__178_B6,5 Lung Primary cancer 3,361 Tumor/Malignant 29.6% 0.54 0.86
NSCLC_38242124__IMC__178_B6,7 Lung Primary cancer 2,274 Tumor/Malignant 63.5% 0.93 0.20
NSCLC_38242124__IMC__178_B6,8 Lung Primary cancer 685 Stromal 48.5% 0.66 0.69
NSCLC_38242124__IMC__178_B6,9 Lung Primary cancer 2,386 Stromal 30.7% 0.48 0.89
NSCLC_38242124__IMC__178_B7,10 Lung Primary cancer 3,110 Tumor/Malignant 85.7% 0.98 0.06
NSCLC_38242124__IMC__178_B7,11 Lung Primary cancer 2,791 Immune 26.8% 0.54 0.75
NSCLC_38242124__IMC__178_B7,12 Lung Primary cancer 3,185 Tumor/Malignant 66.9% 0.96 0.13
NSCLC_38242124__IMC__178_B7,13 Lung Primary cancer 553 Tumor/Malignant 45.6% 0.91 0.24
NSCLC_38242124__IMC__178_B7,14 Lung Primary cancer 2,645 Tumor/Malignant 23.8% 0.79 0.51
NSCLC_38242124__IMC__178_B7,15 Lung Primary cancer 225 Tumor/Malignant 52.0% 0.72 0.50
NSCLC_38242124__IMC__178_B7,17 Lung Primary cancer 3,390 Tumor/Malignant 50.6% 0.95 0.24
NSCLC_38242124__IMC__178_B7,18 Lung Primary cancer 2,443 Stromal 29.4% 0.36 1.04
NSCLC_38242124__IMC__178_B7,3 Lung Primary cancer 3,786 Tumor/Malignant 33.2% 0.55 0.84

Spatial Domain (Tier 2)

2,069 ready
Sample Organ Disease state Cells Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. Domain share Purity Diversity
NSCLC_38242124__IMC__178_B6,14 Lung Primary cancer 3,953 Tumor/Malignant 44.1% 0.99 0.07
NSCLC_38242124__IMC__178_B6,15 Lung Primary cancer 2,326 Tumor/Malignant 33.9% 0.93 0.25
NSCLC_38242124__IMC__178_B6,17 Lung Primary cancer 1,683 Other 24.4% 0.84 0.36
NSCLC_38242124__IMC__178_B6,18 Lung Primary cancer 3,185 Tumor/Malignant 40.1% 0.99 0.06
NSCLC_38242124__IMC__178_B6,2 Lung Primary cancer 3,176 Stromal 24.9% 0.45 1.02
NSCLC_38242124__IMC__178_B6,3 Lung Primary cancer 2,771 Tumor/Malignant 30.0% 0.96 0.18
NSCLC_38242124__IMC__178_B6,4 Lung Primary cancer 2,586 Tumor/Malignant 57.6% 0.98 0.07
NSCLC_38242124__IMC__178_B6,5 Lung Primary cancer 3,361 Tumor/Malignant 26.3% 0.58 0.90
NSCLC_38242124__IMC__178_B6,7 Lung Primary cancer 2,274 Tumor/Malignant 55.6% 0.96 0.14
NSCLC_38242124__IMC__178_B6,8 Lung Primary cancer 685 Stromal 46.7% 0.67 0.68
NSCLC_38242124__IMC__178_B6,9 Lung Primary cancer 2,386 Stromal 24.4% 0.51 0.96
NSCLC_38242124__IMC__178_B7,10 Lung Primary cancer 3,110 Tumor/Malignant 78.6% 1.00 0.02
NSCLC_38242124__IMC__178_B7,11 Lung Primary cancer 2,791 Myeloid 27.1% 0.36 1.05
NSCLC_38242124__IMC__178_B7,12 Lung Primary cancer 3,185 Tumor/Malignant 51.3% 0.97 0.11
NSCLC_38242124__IMC__178_B7,13 Lung Primary cancer 553 Tumor/Malignant 55.9% 0.89 0.33
NSCLC_38242124__IMC__178_B7,14 Lung Primary cancer 2,645 Tumor/Malignant 22.6% 0.81 0.47
NSCLC_38242124__IMC__178_B7,15 Lung Primary cancer 225 Tumor/Malignant 56.0% 0.71 0.54
NSCLC_38242124__IMC__178_B7,17 Lung Primary cancer 3,390 Tumor/Malignant 39.1% 0.79 0.52
NSCLC_38242124__IMC__178_B7,18 Lung Primary cancer 2,443 Stromal 24.8% 0.37 1.05
NSCLC_38242124__IMC__178_B7,3 Lung Primary cancer 3,786 Tumor/Malignant 24.9% 0.59 0.91

Spatial Domain (Tier 3)

2,069 ready
Sample Organ Disease state Cells Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. Domain share Purity Diversity
NSCLC_38242124__IMC__178_B6,14 Lung Primary cancer 3,953 Tumor/Malignant cell 57.6% 0.94 0.18
NSCLC_38242124__IMC__178_B6,15 Lung Primary cancer 2,326 Tumor/Malignant cell 39.9% 0.90 0.31
NSCLC_38242124__IMC__178_B6,17 Lung Primary cancer 1,683 Other 29.2% 0.82 0.43
NSCLC_38242124__IMC__178_B6,18 Lung Primary cancer 3,185 Tumor/Malignant cell 60.5% 0.94 0.21
NSCLC_38242124__IMC__178_B6,2 Lung Primary cancer 3,176 Other 20.0% 0.49 1.03
NSCLC_38242124__IMC__178_B6,3 Lung Primary cancer 2,771 Fibroblast 37.6% 0.79 0.53
NSCLC_38242124__IMC__178_B6,4 Lung Primary cancer 2,586 Tumor/Malignant cell 70.2% 0.95 0.15
NSCLC_38242124__IMC__178_B6,5 Lung Primary cancer 3,361 Tumor/Malignant cell 33.0% 0.81 0.56
NSCLC_38242124__IMC__178_B6,7 Lung Primary cancer 2,274 Tumor/Malignant cell 62.5% 0.94 0.20
NSCLC_38242124__IMC__178_B6,8 Lung Primary cancer 685 Fibroblast 46.4% 0.64 0.73
NSCLC_38242124__IMC__178_B6,9 Lung Primary cancer 2,386 Fibroblast 24.4% 0.73 0.64
NSCLC_38242124__IMC__178_B7,10 Lung Primary cancer 3,110 Tumor/Malignant cell 85.9% 0.98 0.06
NSCLC_38242124__IMC__178_B7,11 Lung Primary cancer 2,791 T cell 29.2% 0.53 0.87
NSCLC_38242124__IMC__178_B7,12 Lung Primary cancer 3,185 Tumor/Malignant cell 65.7% 0.96 0.13
NSCLC_38242124__IMC__178_B7,13 Lung Primary cancer 553 Tumor/Malignant cell 56.1% 0.89 0.33
NSCLC_38242124__IMC__178_B7,14 Lung Primary cancer 2,645 Tumor/Malignant cell 23.8% 0.79 0.51
NSCLC_38242124__IMC__178_B7,15 Lung Primary cancer 225 Tumor/Malignant cell 54.7% 0.72 0.55
NSCLC_38242124__IMC__178_B7,17 Lung Primary cancer 3,390 Tumor/Malignant cell 50.5% 0.95 0.25
NSCLC_38242124__IMC__178_B7,18 Lung Primary cancer 2,443 Fibroblast 29.8% 0.43 1.04
NSCLC_38242124__IMC__178_B7,3 Lung Primary cancer 3,786 Tumor/Malignant cell 36.7% 0.79 0.60